Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease

British Journal of Haematology

Volumn 110, Issue 3, 2000, Pages 704-714

  Nurden, Paquita ^a   Chretien, Fabrice ^a   Poujol, Christel ^a   Winckler, Joelle ^a   Borel Derlon, Annie ^b   Nurden, Alan ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Electron microscopy; Giant platelets; Immunogold labelling; Type 2B von Willebrand disease

Indexed keywords

GLYCOPROTEIN IB; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CASE REPORT; CELL SIZE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; IMMUNOGOLD STAINING; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTE STRUCTURE; VON WILLEBRAND DISEASE;

ADULT; AGED; BLOOD PLATELETS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; MICROTOMY; MUTATION; PLATELET COUNT; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0033772454     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02246.x     Document Type: Article

References (54)

1. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (leu-480/val-481-gly-718) to the N-terminal region of the a-chain of membrane glycoprotein Ib on intact platelets with bis (sulfosuccinimyl) suberate
2. Degrading and non-degrading pathways in fluid-phase (non-adsorptive) endocytosis in human blood platelets
3. Expression of markers of platelet activation and the interpatient variation in response to abciximab
4. Abnormality of glycoprotein Ib in two cases of pseudo-von Willebrand's disease
5. Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor
6. The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GPIb binding domain
7. Eccentric localization of von Willebrand factor in an internal structure of platelet α-granule resembling that of Weibel-Palade bodies
8. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors
9. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations
10. Identification of a binding sequence for the 14-13-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ibα
11. Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor γ-chain, Fyn, and Lyn to activate normal platelets
12. The glycoprotein Ib/IX complex regulates cell proliferation
13. 2+ increase in platelets
14. Platelets from 'giant platelet syndrome (BSS)' are discocytes and normal sized
15. Von Willebrand disease: A database of point mutations, insertions, and deletions
16. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions
17. Platelet aggregation induced by type IIB von Willebrand factor
18. Leu697 -> val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease
19. Von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin
20. Platelets in idiopathic thrombocytopenic purpura are increased in size but are of normal density
21. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes
22. Expressed full-length von Willebrand factor containing missense mutations linked to type IIb von Willebrand disease shows enhanced binding to platelets
23. Von Willebrand's disease, digestive angiodysplasia, and estrogen-progesterone treatment
24. Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease
25. Bernard-Soulier syndrome
26. Type 2B von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy
27. PAICA: A method for characterizing platelet-associated antibodies: Its application to the study of idiopathic thrombocytopenic purpura and to the detection of platelet-bound c7E3
28. Molecular genetics of von Willebrand disease
29. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: From the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand disease
30. Platelet-type von Willebrand disease
31. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites
32. Giant platelet disorder in a patient with type 2B von Willebrand's disease
33. Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor causing type IIB von Willebrand disease
34. Inherited abnormalities of platelets
35. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl-sulfate-polyacrylamide gel electrophoresis
36. Giant platelets, megakaryocytes and the expression of glycoprotein Ib-IX complexes
37. 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibody AP6
38. Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab Fragments (abciximab): Flow and endocytic mechanisms contribute to the transport
39. Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb/IIIa
40. Molecular study of von Willebrand disease: Identification of potential mutations in patients with type IIA and type IIB
41. 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the α-granule membrane
42. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences
43. Further investigations on Bernard-Soulier platelet abnormalities
44. Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease
45. Classification of von Willebrand disease
46. Platelets and von Willebrand disease
47. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease
48. Type IIB Tampa: A variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates and spontaneous platelet aggregation
49. A revised classification of von Willebrand disease
50. Biochemistry and genetics of von Willebrand factor
51. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry
52. Further characterization of platelet-type von Willebrand's disease in Japan
53. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation
54. Three cases of acquired von Willebrand disease associated with systemic lupus erythematous